A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Detemir in Children and Adolescents 1 to Less Than 18 Years With Type 1 Diabetes Mellitus on a Basal-bolus Regimen With Insulin Aspart as Bolus Insulin, Followed by a 26-week Extension Investigating Long Term Safety (BEGIN™: Young 1)
A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Detemir in Children and Adolescents 1 to Less Than 18 Years With Type 1 Diabetes Mellitus on a Basal-bolus Regimen With Insulin Aspart as Bolus Insulin, Followed by a 26-week Extension Investigating Long Term Safety (BEGIN™: Young 1)
This trial is conducted in Africa, Asia, Europe and the United States of America (USA).
The aim of this trial is to investigate the efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes mellitus.
Inclusion Criteria:
Exclusion Criteria:
OYS, 90029, Finland
Kobe-shi, Hyogo, 657-0846, Japan
Kochi-shi, Kochi, 780 0952, Japan
Kumamoto-shi, Kumamoto, 860 8556, Japan
Niigata-shi, Niigata, 951 8520, Japan
Osaka-shi, Osaka, 545 8586, Japan
Sendai-shi, Miyagi, 980 8574, Japan
Toyonaka-city, Osaka, 560 0004, Japan
Tsu-shi, Mie, 514 0125, Japan